2017
DOI: 10.1159/000475277
|View full text |Cite|
|
Sign up to set email alerts
|

MiR-34a Promotes Apoptosis and Inhibits Autophagy by Targeting HMGB1 in Acute Myeloid Leukemia Cells

Abstract: Background: MiR-34a is identified as a tumor suppressor gene and involved in acute myeloid leukemia (AML) development. However, the regulatory mechanism of miR-34a in AML is unclear. Methods: The expression of miR-34a and HMGB1 in HL-60, THP-1 and HS-5 cells were detected by qRT-PCR and western blot. Lipofectamine 2000 was used to transfect with miR-34a mimics, miR-34a inhibitor, si-HMGB1, pcDNA 3.1-HMGB1, and corresponding controls. The apoptosis and autophagy of transfected AML cells were assessed by flow cy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
58
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 89 publications
(61 citation statements)
references
References 39 publications
3
58
0
Order By: Relevance
“…The suppression of miR‐34a expression was related to poor clinical outcome and impaired treatment efficacy in patients suffering from AML, indicating that miR‐34a concentration in LSCs may be an innovative predictor of AML clinical outcome. This observation is in line with the results of the study by Liu et al, wherein miR‐34a suppression was inhibited in AML cells …”
Section: Discussionsupporting
confidence: 92%
“…The suppression of miR‐34a expression was related to poor clinical outcome and impaired treatment efficacy in patients suffering from AML, indicating that miR‐34a concentration in LSCs may be an innovative predictor of AML clinical outcome. This observation is in line with the results of the study by Liu et al, wherein miR‐34a suppression was inhibited in AML cells …”
Section: Discussionsupporting
confidence: 92%
“…HMGB1 could activate autophagy to protect cancer cell from the chemotherapy‐induced apoptosis in leukemia . miR‐34a was reported to target HMGB1 and inhibited the autophagy in acute myeloid leukemia cells . However, the mechanism of miR‐34a/HMGB1 axis in colon cancer remains unknown and needs to be further explored.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have measured the expression of miR-34a in several hematologic diseases, including multiple myeloma (30), primary myelofibrosis (20), and acute myelocytic leukemia (31). These findings revealed the role of miR-34a in lineage choice and fate decision in hematopoiesis.…”
Section: Discussionmentioning
confidence: 88%